Clinical trials
Eye Diseases trials in Canada
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
22 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2005 | 1 |
| 2008 | 1 |
| 2009 | 2 |
| 2018 | 1 |
| 2019 | 3 |
| 2020 | 3 |
| 2021 | 4 |
| 2022 | 2 |
| 2023 | 3 |
| 2024 | 1 |
| 2025 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Terminated | 4 |
| Active, not recruiting | 3 |
| Unknown status | 3 |
| Recruiting | 2 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ProQR Therapeutics | 3 |
| Centre hospitalier de l'Université de Montréal (CHUM) | 2 |
| Laboratoires Thea | 2 |
| London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's | 2 |
| Novartis Pharmaceuticals | 2 |
| AbbVie | 1 |
| Bausch & Lomb Incorporated | 1 |
| CooperVision, Inc. | 1 |
| Elisigen, Inc. | 1 |
| Jaeb Center for Health Research | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Eye Diseases | 22 |
| Retinal Diseases | 10 |
| Vision Disorders | 6 |
| Retinal Degeneration | 5 |
| Eye Abnormalities | 4 |
| Eye Diseases, Hereditary | 4 |
| Macular Degeneration | 4 |
| Wet Macular Degeneration | 4 |
| Blindness | 3 |
| Choroidal Neovascularization | 3 |
Trials
Showing 26 to 22 of 22. Each trial links to its page on Pharma Observatory.
No trials match these filters.
Try a different keyword, or clear a filter.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.